When Pfizer began its virtual trial in 2011, the technology it used was at the forefront of innovation in clinical research. Yet two years later, some of the ideas are already looking dated, with the rise of smartphones meaning Pfizer now foresees participants using their own devices, instead of dedicated tools.
Sony has filed a patent for a "SmartWig," a replacement head of hair that also tracks the wearer's blood pressure, temperature and other metrics.
In the 20 months since the White House unveiled its $200 million Big Data R&D initiative, the field has matured and begun to fulfill its potential. Now the government has inked a batch of data-related projects and signed up Eli Lilly, Novartis and Pfizer as partners.
When the European Medicines Agency released its draft policy on clinical trial data disclosure in June, it expected a big response. And it got one, with more than 1,000 comments submitted in the four-month consultation period. Working through this feedback is taking a little longer than expected, though.
Veeva Systems CEO Peter Gassner spoke to Forbes about the company and its plans to expand its products.
GoBalto has introduced version 2.0 of Tracker, its software-as-a-service platform designed to streamline clinical trial startup.
Smartphones and tablets succeed or sink on the strength of their apps. Over the past few years, this has given Apple ($AAPL) a huge advantage. If you wanted the latest apps, Apple was the only...
The growing pool of genomics data and bioinformatics capabilities present new opportunities to improve outcomes for cancer patients. Yet without coordinated, multidisciplinary collaborations, the industry risks failing to take full advantage, researchers warned this week.
Patients who have participated in Pfizer clinical trials will be able to download their data using the 'Blue Button' standard introduced by the White House.
Qlucore, a provider of scientific software, has won €600,000 ($801,360) over three years from the European Commission's 7th Framework Program to develop algorithms for use in personalizing treatment of hepatitis C virus.